loadpatents
name:-0.013290166854858
name:-0.0064470767974854
name:-0.0042757987976074
OFIR; Rachel Patent Filings

OFIR; Rachel

Patent Applications and Registrations

Patent applications and USPTO patent grants for OFIR; Rachel.The latest application filed is for "methods and compositions for treating subjects exposed to vesicants and other chemical agents".

Company Profile
5.9.21
  • OFIR; Rachel - Adi IL
  • Ofir; Rachel - Mitzpe Adi IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions For Treating Subjects Exposed To Vesicants And Other Chemical Agents
App 20210353687 - EISENKRAFT; Arie ;   et al.
2021-11-18
Therapeutic Methods And Compositions
App 20210338740 - ABERMAN; Zami ;   et al.
2021-11-04
Methods And Compositions For Treating Viral Infections
App 20210283189 - Yanay; Yaacob ;   et al.
2021-09-16
Therapeutic Dosage Regimens Comprising Adherent Stromal Cells
App 20210228635 - ABERMAN; Zami ;   et al.
2021-07-29
Methods And Compositions For Treating Cancers And Neoplasms
App 20210205370 - Aberman; Zami ;   et al.
2021-07-08
Methods And Compositions For Treating Neurological Disorders
App 20200246386 - Kind Code
2020-08-06
Methods And Compositions For Treating Addictions
App 20200155611 - YADID; Gal ;   et al.
2020-05-21
Methods And Compositions For Tumor Assessment
App 20200080147 - ABERMAN; Zami ;   et al.
2020-03-12
Gene and protein expression properties of adherent stromal cells cultured in 3D
Grant 10,351,910 - Ofir , et al. July 16, 2
2019-07-16
Methods and compositions for treating and preventing muscle wasting disorders
Grant 10,258,652 - Lukasiewicz Hagai , et al.
2019-04-16
Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy
App 20180256648 - Meiron; Moran ;   et al.
2018-09-13
Methods And Compositions For Treating And Preventing Muscle Wasting Disorders
App 20170304370 - Lukasiewicz Hagai; Esther ;   et al.
2017-10-26
Adherent cells from adipose or placenta tissues and use thereof in therapy
Grant 9,517,248 - Meiron , et al. December 13, 2
2016-12-13
Gene And Protein Expression Properties Of Adherent Stromal Cells Cultured In 3d
App 20160186259 - Ofir; Rachel ;   et al.
2016-06-30
Adherent cells from placenta tissue and use thereof in therapy
Grant 9,096,827 - Meiron , et al. August 4, 2
2015-08-04
Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy
App 20140242039 - Meiron; Moran ;   et al.
2014-08-28
Adherent Cells From Placenta Tissue And Use Thereof In Therapy
App 20130337558 - Meiron; Moran ;   et al.
2013-12-19
Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy
App 20130323213 - Meiron; Moran ;   et al.
2013-12-05
Adherent cells from adipose or placenta tissues and use thereof in therapy
Grant 8,529,888 - Meiron , et al. September 10, 2
2013-09-10
Adherent cells from placenta tissue and use thereof in therapy
Grant 8,524,496 - Meiron , et al. September 3, 2
2013-09-03
Adherent Cells From Placenta Tissue And Use Thereof In Therapy
App 20110256160 - Meiron; Moran ;   et al.
2011-10-20
Adherent Cells From Placenta Tissue And Use Thereof In Therapy
App 20110256159 - Meiron; Moran ;   et al.
2011-10-20
Methods Of Selection Of Cells For Transplantation
App 20110256108 - Meiron; Moran ;   et al.
2011-10-20
Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy
App 20100209403 - Meiron; Moran ;   et al.
2010-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed